Sarcura GmbH, a start-up company founded in November 2019, develops a machine platform for the industrial manufacturing of personalised cell therapeutics used in cancer treatment. Sarcura envisions to transform existing manufacturing paradigms by using semiconductor technology embedded in microfluidic liquid processing systems to bring bioprocess control to cellular level in order to scale global manufacturing capacity.
Obere Haselbacherstraße 9
3413 St. Andrä-Wördern
Contact: Daniela Buchmayr (CEO)